IP Library Granted Patent US 11,547,447
Granted Patent B2
US 11,547,447 · App. 17/181,539 · Granted Jan 10, 2023

Implantable fluid delivery devices, systems, and methods

Inventors: David Mathew Johnson (San Francisco, CA); Scott A. Uhland (San Jose, CA); Robert Thomas Krivacic (San Jose, CA); Ramkumar Abhishek (Mountain View, CA); Martin Sheridan (Redwood City, CA)
Assignee: Palo Alto Research Center Incorporated
A61B17/43A61D7/00A61M31/002A61B17/435
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,547,447
App. No.
17/181,539
Filed
Feb 22, 2021
Granted
Jan 10, 2023
Kind
B2
Art Unit
3791
USPC
600/34
Abstract

Devices, systems, and methods for delivering fluid are provided. Devices include a housing configured for intravaginal deployment and retention, at least one reservoir configured to contain a fluid, and a fluid dispensing mechanism configured to dispense the fluid past the cervix and to the uterus of the subject. Methods include intravaginally deploying and retaining a device in the subject, and dispensing the fluid from the device such that the fluid is driven past the cervix to the uterus of the subject.

Claims (23)

1. An implantable fluid delivery system, comprising:

a device comprising a housing configured for intravaginal deployment and retention in a subject and a fluid dispensing mechanism disposed within the housing; and

a capsule containing a fluid to be delivered to the subject, the capsule being configured to be inserted past the cervix of the subject prior to deployment of the device,

wherein the fluid dispensing mechanism comprises an ultrasonic element configured to generate an ultrasonic wave effective to rupture the capsule and release the fluid to the uterus of the subject.

2. The system of claim 1 , wherein the ultrasonic element comprises a piezoelectric material and an acoustic horn.

3. The system of claim 1 , wherein the device is configured to dispense the fluid when an estrus condition of the subject detected by the device meets a predetermined threshold.

4. The system of claim 1 , wherein the fluid is selected from the group consisting of drugs, semen, ova, and combinations thereof.

5. The system of claim 4 , wherein the fluid comprises a combination of drugs.

6. The system of claim 4 , wherein the fluid comprises a combination of two or more of drugs, semen, and ova.

7. The system of claim 1 , wherein the device comprises a power source, a microcontroller, and an activation mechanism.

8. The system of claim 1 , wherein the subject is one of a horse, cow, sheep, and sow.

9. The system of claim 1 , further comprising a deployment device configured to insert the capsule past the cervix of the subject.

10. A method of delivering fluid to a subject, comprising:

inserting a capsule containing a fluid to be delivered to the subject past the cervix of the subject;

thereafter intravaginally deploying a device in the subject, the device comprising a fluid dispensing mechanism, which comprises an ultrasonic element; and

generating an ultrasonic wave, via the ultrasonic element, effective to rupture the capsule and release the fluid to the uterus of the subject.

11. The method of claim 10 , wherein the ultrasonic element comprises a piezoelectric material and an acoustic horn.

12. The method of claim 10 , wherein generating an ultrasonic wave occurs in response to the device detecting an estrus condition of the subject meeting a predetermined threshold.

13. The method of claim 10 , wherein the fluid is selected from the group consisting of drugs, semen, ova, and combinations thereof.

14. The method of claim 13 , wherein the fluid comprises a combination of drugs.

15. The method of claim 13 , wherein the fluid comprises a combination of two or more of drugs, semen, and ova.

16. The method of claim 1 , wherein the subject is one of a horse, cow, sheep, and sow.

17. The method of claim 10 , wherein inserting the capsule comprises activating a deployment device configured to insert the capsule past the cervix of the subject.

Assignments (9)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2025
From: XEROX CORPORATION
To: GENESEE VALLEY INNOVATIONS, LLC
Reel/Frame 073842/0479 →
SECOND LIEN NOTES PATENT SECURITY AGREEMENT Recorded Jul 2, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 071785/0550 →
FIRST LIEN NOTES PATENT SECURITY AGREEMENT Recorded Apr 11, 2025
From: XEROX CORPORATION
To: U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 070824/0001 →
SECURITY INTEREST Recorded Feb 13, 2024
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 066741/0001 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT RF 064760/0389 Recorded Feb 13, 2024
From: CITIBANK, N.A., AS COLLATERAL AGENT
To: XEROX CORPORATION
Reel/Frame 068261/0001 →
SECURITY INTEREST Recorded Nov 20, 2023
From: XEROX CORPORATION
To: JEFFERIES FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 065628/0019 →
CORRECTIVE ASSIGNMENT TO CORRECT THE REMOVAL OF US PATENTS 9356603, 10026651, 10626048 AND INCLUSION OF US PATENT 7167871 PREVIOUSLY RECORDED ON REEL 064038 FRAME 0001. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 28, 2023
From: PALO ALTO RESEARCH CENTER INCORPORATED
To: XEROX CORPORATION
Reel/Frame 064161/0001 →
SECURITY INTEREST Recorded Jun 22, 2023
From: XEROX CORPORATION
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 064760/0389 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2023
From: PALO ALTO RESEARCH CENTER INCORPORATED
To: XEROX CORPORATION
Reel/Frame 064038/0001 →